292 related articles for article (PubMed ID: 34155232)
1. The risk of pancreatic adenocarcinoma following SARS-CoV family infection.
Ebrahimi Sadrabadi A; Bereimipour A; Jalili A; Gholipurmalekabadi M; Farhadihosseinabadi B; Seifalian AM
Sci Rep; 2021 Jun; 11(1):12948. PubMed ID: 34155232
[TBL] [Abstract][Full Text] [Related]
2. The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1.
Alsamman AM; Zayed H
PLoS One; 2020; 15(12):e0243270. PubMed ID: 33301474
[TBL] [Abstract][Full Text] [Related]
3. Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells.
Yang M; Li J; Deng S; Fan H; Peng Y; Ye G; Wang J; Wei J; Jiang X; Xu Z; Qing L; Wang F; Yang Y; Liu Y
Cells; 2022 Jan; 11(3):. PubMed ID: 35159296
[TBL] [Abstract][Full Text] [Related]
4. Prediction of potential therapeutic drugs against SARS-CoV-2 by using Connectivity Map based on transcriptome data.
Chen WY; Fang ZX; Lv XD; Zhou QH; Yao M; Deng M
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):3122-3131. PubMed ID: 33877681
[TBL] [Abstract][Full Text] [Related]
5. H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection.
Zhou N; Bao J; Ning Y
BMC Bioinformatics; 2021 Jan; 22(1):18. PubMed ID: 33413085
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
Elife; 2021 Apr; 10():. PubMed ID: 33861198
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.
Marston JL; Greenig M; Singh M; Bendall ML; Duarte RRR; Feschotte C; Iñiguez LP; Nixon DF
JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34731091
[TBL] [Abstract][Full Text] [Related]
8. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
Wu Z; Harrich D; Li Z; Hu D; Li D
Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
[TBL] [Abstract][Full Text] [Related]
9. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.
Abdelrahman Z; Li M; Wang X
Front Immunol; 2020; 11():552909. PubMed ID: 33013925
[TBL] [Abstract][Full Text] [Related]
10. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387
[TBL] [Abstract][Full Text] [Related]
11. No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020.
Panatto D; Orsi A; Pennati BM; Lai PL; Mosca S; Bruzzone B; Caligiuri P; Napoli C; Bertamino E; Orsi GB; Manini I; Loconsole D; Centrone F; Pandolfi E; Ciofi Degli Atti ML; Concato C; Linardos G; Onetti Muda A; Raponi M; Piccioni L; Rizzo C; Chironna M; Icardi G
PLoS One; 2021; 16(12):e0260947. PubMed ID: 34874956
[TBL] [Abstract][Full Text] [Related]
12. Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2.
Xie LM; Huang YF; Liu YL; Liang JQ; Deng W; Lin GL; Luo HM; Guo XG
Biochem Genet; 2022 Dec; 60(6):2052-2068. PubMed ID: 35235083
[TBL] [Abstract][Full Text] [Related]
13. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
Krishnamoorthy P; Raj AS; Roy S; Kumar NS; Kumar H
Comput Biol Med; 2021 Jan; 128():104123. PubMed ID: 33260034
[TBL] [Abstract][Full Text] [Related]
14. Severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), influenza, and COVID-19, beyond the lungs: a review article.
Lombardi AF; Afsahi AM; Gupta A; Gholamrezanezhad A
Radiol Med; 2021 Apr; 126(4):561-569. PubMed ID: 33242204
[TBL] [Abstract][Full Text] [Related]
15. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
16. Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.
Davies JP; Almasy KM; McDonald EF; Plate L
ACS Infect Dis; 2020 Dec; 6(12):3174-3189. PubMed ID: 33263384
[TBL] [Abstract][Full Text] [Related]
17. Respiratory viral infections during pregnancy: effects of SARS-CoV-2 and other related viruses over the offspring.
Riedel C; Rivera JC; Canedo-Marroquín G; Kalergis AM; Opazo MC
J Dev Orig Health Dis; 2022 Feb; 13(1):3-8. PubMed ID: 33526164
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: An in silico study.
Gomez Marti JL; Wells A; Brufsky AM
J Med Virol; 2021 Apr; 93(4):2396-2405. PubMed ID: 33331649
[TBL] [Abstract][Full Text] [Related]
19. An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2.
Xie TA; He ZJ; Liang C; Dong HN; Zhou J; Fan SJ; Guo XG
Eur J Med Res; 2021 Dec; 26(1):146. PubMed ID: 34920753
[TBL] [Abstract][Full Text] [Related]
20. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
Stukalov A; Girault V; Grass V; Karayel O; Bergant V; Urban C; Haas DA; Huang Y; Oubraham L; Wang A; Hamad MS; Piras A; Hansen FM; Tanzer MC; Paron I; Zinzula L; Engleitner T; Reinecke M; Lavacca TM; Ehmann R; Wölfel R; Jores J; Kuster B; Protzer U; Rad R; Ziebuhr J; Thiel V; Scaturro P; Mann M; Pichlmair A
Nature; 2021 Jun; 594(7862):246-252. PubMed ID: 33845483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
